| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.2M | -23.7% |
| Cost of Revenue | $22.5M | -35.2% |
| Gross Profit | $5.8M | +148.2% |
| R&D Expense | $2.6M | +14.3% |
| SG&A Expense | $28.0M | -12.6% |
| Operating Income | -$22.2M | +25.2% |
| Interest Expense | $3.1M | +8326.3% |
| Pre-tax Income | -$25.5M | -34.9% |
| Net Income | -$25.5M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $681K | -80.7% |
| Accounts Receivable | $1.6M | -22.5% |
| Inventory | $3.8M | -43.8% |
| Current Assets | $15.6M | -37.6% |
| Total Assets | $47.0M | -17.0% |
| Current Liabilities | $22.5M | +66.9% |
| Long-term Debt | $6.1M | +558.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.9M | +46.8% |
| Investing Cash Flow | -$241K | +91.8% |
| Financing Cash Flow | $7.4M | +206.1% |
| -34.9% |
| EPS (Basic) | -$9.22 | -8.5% |
| EPS (Diluted) | -$9.22 | -8.5% |
| Total Liabilities |
| $35.6M |
| +75.0% |
| Stockholders' Equity | $11.4M | -68.5% |